OTCMKTS:EMBI Emerald Bioscience (EMBI) Stock Price, News & Analysis → This company has increased its dividend every year for 54 years (From DTI) (Ad) Free EMBI Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.09▼$17.7552-Week Range N/AVolume6.96 million shsAverage Volume14.24 million shsMarket Capitalization$24.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Emerald Bioscience alerts: Email Address Ad DTIDon’t expose yourself to stocks during the weekThe S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.Click here and I’ll give you all the details. About Emerald Bioscience Stock (OTCMKTS:EMBI)Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is based in San Diego, California.Read More Ad DTIDon’t expose yourself to stocks during the weekThe S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.Click here and I’ll give you all the details. EMBI Stock News HeadlinesApril 16, 2024 | benzinga.comCannabis Bioscience Stock (OTC:CBIH), Quotes and News SummaryApril 10, 2024 | americanbankingnews.comEmerald Bioscience (OTCMKTS:EMBI) Reaches New 1-Year High at $9.23April 19, 2024 | Darwin (Ad)2024's Must-Have Guide: Master Crypto Investment TodayThe cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)February 21, 2024 | finance.yahoo.comDaré Bioscience, Inc. (DARE)January 17, 2024 | wsj.comStar Lake Bioscience Co. Ltd. Guangdong Zhaoqing ANovember 15, 2023 | lse.co.ukBnp Paribas Easy Jpm Esg Embi Global Diversified Composite Ucits Etf H Eur Cap Share Price (EMBH.PA)September 6, 2023 | bizjournals.comConstruction starts on $55M senior living project in RedmondFebruary 21, 2023 | duluthnewstribune.comDuluth takes less aggressive stance against emerald ash borers, prepares to cutApril 19, 2024 | DTI (Ad)Don’t expose yourself to stocks during the weekThe S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.July 11, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Reports 2022 Q1 ResultsSee More Headlines Receive EMBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:EMBI CUSIPN/A CIKN/A Webwww.emeraldbio.life Phone949-336-3443FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.05 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-347.62% Debt Debt-to-Equity Ratio0.43 Current Ratio3.59 Quick Ratio3.59 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares268,074,000Free FloatN/AMarket Cap$24.13 million OptionableNot Optionable Beta0.43 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Punit S. Dhillon B.A. (Age 40)BA, Exec. Chairman & CEO Comp: $65kMr. Richard JanneyInterim Principal Accounting OfficerMs. Elena Traistaru (Age 61)Company Sec. Key CompetitorsDURECTNASDAQ:DRRXAddex TherapeuticsNASDAQ:ADXNSANUWAVE HealthOTCMKTS:SNWVInspira Technologies Oxy B.H.N.NASDAQ:IINNLisata TherapeuticsNASDAQ:LSTAView All Competitors EMBI Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Emerald Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Bioscience investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Charlotte's Web (CWBHF), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cognex (CGNX), Cumberland Pharmaceuticals (CPIX), Corbus Pharmaceuticals (CRBP) and Editas Medicine (EDIT). How do I buy shares of Emerald Bioscience? Shares of EMBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EMBI) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Bioscience Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.